BIIB
reuters.dev
http://www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FBIIB.O%2Fkey-developments%2Farticle%2F2773115&ei=knKaUpCMFoqw0AGZAw&usg=AFQjCNENI9CFL87HVTpYqIUMQB6JpwpQUA
Biogen Idec Inc Raises FY 2013 Revenue Guidance; Reaffirms FY 2013 EPS Guidance-Conference Call
Monday, 10 Jun 2013 01:30pm EDT
Biogen Idec Inc announced that for fiscal 2013, it expects to see high teens revenue growth and then non-GAAP diluted earnings per share between $7.80 and $7.90. The Company reported revenues of $5.5 billion in fiscal 2012. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $6.55 billion for fiscal 2013.Â 
